Computerized Wheeze Detectors — CPB 0813 | AETNA Coverage Update

Aetna modified CPB 0813 for computerized wheeze detectors, effective December 4, 2025. Here's what billing teams need to know.

Aetna, a CVS Health company, updated CPB 0813 to classify all uses of computerized and electronic wheeze detectors as experimental, investigational, or unproven. This Aetna computerized wheeze detector coverage policy applies to diagnostic evaluation of lung sounds — including wheezing and cough — across ICD-10 codes in the R05 and R06 ranges. If your practice bills for wheeze detection devices or cough monitoring technology for Aetna members, this coverage policy shuts that door completely.

Quick-Reference Table

Aetna Computerized Wheeze Detector Coverage Criteria and Medical Necessity Requirements 2025

The Aetna computerized wheeze detector coverage policy under CPB 0813 is unambiguous. Aetna does not cover computerized or electronic wheeze detectors for any indication. There is no medical necessity pathway that gets you to a covered claim here.

The policy covers both intermittent and continuous devices. It applies to any device used to evaluate lung sounds — wheezing, cough, breathing abnormalities — regardless of the clinical setting or the patient's diagnosis.

From a medical necessity standpoint, Aetna's position is that evidence doesn't support the effectiveness of these devices. That's the formal language. What it means in practice: no matter how thorough your documentation, no matter how clearly you establish wheezing or a respiratory condition, Aetna will not reimburse for computerized wheeze detection. Medical necessity criteria simply don't apply when the technology itself is classified as experimental.

Prior authorization doesn't help you here either. There's no prior authorization pathway listed in CPB 0813 because the policy excludes all indications outright. Seeking prior auth before billing won't change the outcome. The technology is the issue, not the diagnosis or documentation.

This is worth flagging to your medical director. Clinicians sometimes assume that newer monitoring technology will get covered if they document well enough. CPB 0813 says otherwise — and it does so broadly, covering every variation of the device type and every respiratory indication.

Aetna Computerized Wheeze Detector Exclusions and Non-Covered Indications

The exclusion here is total. Aetna classifies computerized wheeze detectors as experimental, investigational, or unproven for every clinical indication listed in CPB 0813.

The policy explicitly names diagnostic evaluation of lung sounds — including wheezing — and cough as covered examples of what is not covered. That phrasing matters. Aetna isn't saying "some uses are experimental." It's saying all uses are experimental.

The "all other indications" language in CPB 0813 closes any remaining gaps. Even if you find a clinical use case not explicitly named in the policy, Aetna's catch-all language applies. There is no off-label or emerging-indication argument that gets you to reimbursement under this policy.

This is similar to how Aetna handles other device-based diagnostics it considers insufficiently validated — the policy draws a hard line around the technology itself rather than around specific uses. If your revenue cycle team was waiting for a narrow exclusion to find a billing path, that path doesn't exist in CPB 0813.

Coverage Indications at a Glance

Aetna Computerized Wheeze Detector Billing Guidelines and Action Items 2025

Computerized wheeze detector billing for Aetna members should stop now if it hasn't already. The effective date is December 4, 2025, and every claim submitted after that date risks a clean denial.

Here are the specific steps your billing team should take:

The real issue here is that experimental classifications are almost impossible to appeal through standard medical necessity channels. Your energy is better spent on prevention — stopping the claims before they go out — than on recovery after denial.

CPT, HCPCS, and ICD-10 Codes for Computerized Wheeze Detectors Under CPB 0813

CPB 0813 does not list specific CPT or HCPCS codes for computerized wheeze detectors. This is not uncommon for policies covering emerging or experimental device categories — the technology exists but hasn't been assigned stable, widely-used billing codes in the standard CPT/HCPCS system. If your practice has been billing these services, your billing team may have been using unlisted procedure codes or miscellaneous HCPCS codes. Either way, the coverage policy forecloses reimbursement regardless of the code used.

If you're uncertain which codes your team has been using for wheeze detection devices, pull a report by diagnosis code. The ICD-10 codes below are the starting point for identifying affected claims.

Key ICD-10-CM Diagnosis Codes Under CPB 0813

These are the 19 codes explicitly listed in CPB 0813. All of them fall under Aetna's experimental classification when paired with computerized wheeze detection services.

The R05 series covers cough in all its specificity — acute, chronic, subacute, and unspecified. The R06 series covers the full range of breathing abnormalities, from dyspnea (R06.0) to wheezing (R06.2) to stridor (R06.1) to other specified and unspecified abnormalities.

If your team bills R06.2 specifically — that's the wheezing code — paired with any computerized detection device for Aetna, that claim is not going to pay under CPB 0813.

One note on coding granularity: the ICD-10-CM R05 and R06 categories have expanded in recent years with more specific subcodes. The policy lists these codes at the category level, which means the experimental designation applies across all subcategories. Don't look for a more specific subcode that might fall outside CPB 0813's scope. Aetna's "all other indications" language in the policy covers that angle.